...
首页> 外文期刊>Drug delivery. >Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy
【24h】

Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy

机译:高强度聚焦超声介导的热敏感脂质体阿霉素腹膜内递送用于癌症化疗的数值模型

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Although intraperitoneal chemotherapy (IPC) has been suggested as a promising method for the management of peritoneal dissemination (PD) of ovarian or colorectal cancers, the actual clinical use of this method has been restricted due to such problems as poor drug penetration into the tumor and high side effects. It is, therefore, necessary to develop new strategies to improve the efficacy of this approach. In the present work, a new strategy is proposed based on intraperitoneal (IP) injection of thermosensitive liposomal doxorubicin (TSL-Dox) with triggered release by mild hyperthermia induced by high intensity focused ultrasound (HIFU). A computational model is developed to evaluate the proposed drug delivery system. Results show an order of magnitude increase in drug penetration depth into the tumor compared to the conventional IP delivery. Furthermore, the effects of thermal conditions applied to the tumor, TSL size, tumor vessel permeability, and tumor size are investigated. Results indicate an improved efficiency of the drug delivery by expanding the heated region, yet, it increases the risk of unintentional TSL drug load release in the peritoneal cavity. Results also indicate that smaller TSLs have better treatment outcome. However, there is a significant reduction in treatment efficacy for TSLs with sizes smaller than the vessel wall pore size. Thus, tuning the size of TSL should be based on the tumor microvascular permeability. The simulation results suggest that the TSL-Dox delivery system in smaller tumors is far advantageous than larger ones. Results of our model can be used as guidelines for future preclinical studies.
机译:尽管腹膜内化疗(IPC)已被建议作为治疗卵巢癌或大肠癌腹膜扩散(PD)的一种有前途的方法,但由于诸如药物难以渗透到肿瘤和高副作用。因此,有必要开发新的策略来提高这种方法的有效性。在目前的工作中,提出了一种新的策略,该方法基于腹膜内(IP)注射热敏脂质体阿霉素(TSL-Dox),并由高强度聚焦超声(HIFU)引起的轻度高温触发释放。开发了计算模型以评估所提出的药物输送系统。结果显示,与常规IP递送相比,药物在肿瘤中的渗透深度增加了一个数量级。此外,研究了热条件对肿瘤,TSL大小,肿瘤血管通透性和肿瘤大小的影响。结果表明,通过扩大加热区域可以提高药物输送效率,但是,它会增加腹膜腔内无意释放TSL药物负荷的风险。结果还表明,较小的TSL具有更好的治疗效果。然而,尺寸小于血管壁孔尺寸的TSL的治疗功效显着降低。因此,调整TSL的大小应基于肿瘤微血管的通透性。仿真结果表明,较小的肿瘤中的TSL-Dox输送系统远优于较大的肿瘤。我们模型的结果可以用作未来临床前研究的指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号